A detailed history of Virtus ETF Advisers LLC transactions in Liquidia Corp stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 6,860 shares of LQDA stock, worth $98,303. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,860
Previous 6,741 1.77%
Holding current value
$98,303
Previous $80,000 15.0%
% of portfolio
0.03%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.9 - $14.11 $1,059 - $1,679
119 Added 1.77%
6,860 $68,000
Q2 2024

Aug 14, 2024

SELL
$11.96 - $15.71 $61,522 - $80,812
-5,144 Reduced 43.28%
6,741 $80,000
Q1 2024

May 15, 2024

SELL
$11.35 - $16.73 $9,250 - $13,634
-815 Reduced 6.42%
11,885 $175,000
Q4 2023

Feb 15, 2024

BUY
$5.77 - $12.19 $773 - $1,633
134 Added 1.07%
12,700 $152,000
Q3 2023

Nov 07, 2023

SELL
$6.27 - $8.15 $7,843 - $10,195
-1,251 Reduced 9.05%
12,566 $79,000
Q2 2023

Aug 14, 2023

BUY
$6.63 - $9.9 $91,606 - $136,788
13,817 New
13,817 $108,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $922M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.